CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,661 | +36.8% | 19,159 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $208,773 | +174.7% | 19,066 | -22.9% | 0.00% | – |
| Q1 2022 | $76,000 | -17.4% | 24,721 | -8.7% | 0.00% | – |
| Q4 2021 | $92,000 | +7.0% | 27,065 | +14.6% | 0.00% | – |
| Q3 2021 | $86,000 | -34.8% | 23,622 | -22.2% | 0.00% | – |
| Q2 2021 | $132,000 | +3.9% | 30,378 | +8.3% | 0.00% | – |
| Q1 2021 | $127,000 | -14.8% | 28,039 | +7.9% | 0.00% | -100.0% |
| Q4 2020 | $149,000 | +4.9% | 25,981 | +32.6% | 0.00% | 0.0% |
| Q3 2020 | $142,000 | +100.0% | 19,592 | -4.1% | 0.00% | – |
| Q2 2020 | $71,000 | +255.0% | 20,419 | +51.4% | 0.00% | – |
| Q1 2020 | $20,000 | -57.4% | 13,485 | -44.3% | 0.00% | – |
| Q4 2019 | $47,000 | -65.2% | 24,195 | -8.5% | 0.00% | -100.0% |
| Q3 2019 | $135,000 | -28.6% | 26,444 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $189,000 | -46.6% | 26,360 | -1.2% | 0.00% | -50.0% |
| Q1 2019 | $354,000 | +71.0% | 26,682 | +1.2% | 0.00% | +100.0% |
| Q4 2018 | $207,000 | – | 26,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |